HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

Greenspring Associates

Lightspeed Venture Partners

Abingworth

Deerfield

Deerfield Management

Frazier Healthcare Partners

Richard King Mellon Foundation

Sahsen Ventures

Biotechnology Value Fund

BVF Partners

Catalys Pacific

Perceptive Advisors

Qiming Venture Partners USA

RA Capital Management

HilleVax

Our IT team is seeking a Senior Technical Support Engineer!
https://lnkd.in/emafBCiq

Our Legal Team is hiring a Contracts Manager!
https://lnkd.in/eR9-fmej

Our CMO team is hiring for Development Strategy Project Coordinator!
https://lnkd.in/exTkT3yq

Our Technical Operations team is hiring for Associate Director, Reference Standard and Stability Management!
https://lnkd.in/eb9f45iG

Our Technical Operations Team is seeking a Senior Director, Analytical Research and Development!
https://lnkd.in/e4fWe6Jq

Our Technical Operations team is hiring a Director of Bioprocess Development!
https://lnkd.in/eWAvi_qt

Our Quality Team is seeking a Quality Assurance Manager on the East Coast!
https://lnkd.in/eEdght8A

Medical Director (MD)- We are seeking East Coast Candidates to join our CMO Team
https://lnkd.in/g66CwTyD

Our Research and Pre-Clinical Development team is hiring an associate scientist to be on-site daily in our new Boston lab!

https://lnkd.in/dAhDkkf9

Our Research and Pre-Clinical Development team is hiring an associate scientist to be on-site daily in our new Boston lab!

https://lnkd.in/eBkAWh5w

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

COM:HILLEVAX

HilleVax, Inc.

Last Close

1.94

08/11 21:00

Market Cap

81.05M

Beta: -

Volume Today

148.74K

Avg: -

Filings Not Available